Categories: News

Due to COVID-19, Pain Therapeutics Conference Will be Accessed Remotely

SMi Group reports: Pain Therapeutics conference will reconvene on 11th and 12 May by remote access.

London, United Kingdom, April 04, 2020 –(PR.com)– Regarding concerns over COVID-19 SMi’s 20th Annual Pain Therapeutics conference will return on the 11th and 12th May 2020 via remote access only. The two-day conference will provide delegates the chance to explore all areas of pain therapeutics, such as pain treatment highlighting clinical success to date as well as evaluating the potential of drug candidates in the pipelines of the top pharmaceutical organisations.

The conference will look to discover novel drug targets for pain management, diverse research strategies and novel pre-clinical models and discuss how leading pharma companies are utilising these to reduce pain across a range of medical conditions.

For those interested, registration is available online at www.pain-therapeutics.co.uk/PR4

Featured topics include:
• Facilitating Pain Research via Biomarkers Discovery
• Novel Drug Targets on the Horizon
• Targets with clinical evidence provided by serendipity
• Learn from Opioid crisis
• The Impact of Chronic Pain – The Patients Perspective
• Migraine Treatment
• The Grunenthal approach to tackle the underlying pathophysiology’s of pain
• Limitation of Migraine Treatment
• Learn about DENKI and PL37 MOA

The two-day programme will consist of keynote presentations from leading pharma organisations such as Centrexion Therapeutics, Collegium Pharma, Mundipharma Research Ltd, Eli Lily, Pain Alliance Ltd, Janssen and more.

Discover the latest innovations in analgesic therapies at this conference with the Co-chairs, Kerrie Brady from Centrexion Therapeutics and Michael Scherz from Metys Pharmaceuticals, who will be chairing the two-day conference with remote access only.

The updated programme and speaker line-up can be seen at www.pain-therapeutics.co.uk/PR4

For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pain Therapeutics 2020
Conference: 11th – 12th May 2020
Remote Access Only
www.pain-therapeutics.co.uk/PR4
#SMiPain

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Let’s block ads! (Why?)

Miscw.com

Recent Posts

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

HONG KONG SAR - Media OutReach Newswire - 10 March 2026 - CK Life Sciences…

51 minutes ago

OPPO Announces Global Launch of Find N6 on March 17th, Redefining Foldables with Zero-Feel Crease Engineered for Lasting Flatness

SHENZHEN, CHINA - Media OutReach Newswire - 9 March 2026 - OPPO, the world's leading…

1 day ago

1win Arranges Private Charter Flights for VIP Clients Leaving the UAE Amid Aviation Disruptions

DUBAI, UAE - Media OutReach Newswire - 9 March 2026 - As aviation disruptions continue…

1 day ago

CGTN: How China builds consensus, boosts development through consultative democracy

BEIJING, CHINA - Media OutReach Newswire - 7 March 2026 - CGTN published an article…

3 days ago

Hong Kong Tech “Proposed with a Ring” and Won Third Place at MedTech Innovation World Cup 2026

HONG KONG SAR - Media OutReach Newswire - 6 March 2026 - Hong Kong Science…

4 days ago

Huawei Highlights Digital Inclusion and Conservation Tech as AI Use Accelerates

BARCELONA, SPAIN - Media OutReach Newswire - 5 March 2026 - Huawei gathered partners, policymakers…

5 days ago